DOCS
Get informed when a big investor buys or sells
+ FollowUndervalued by 35.8% based on the discounted cash flow analysis.
| Market cap | $5.22 Billion |
|---|---|
| Enterprise Value | $5.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.05 |
| Beta | 1.25 |
| Outstanding Shares | 182,569,000 |
| P/E Ratio | 31.38 |
|---|---|
| PEG | -57.69 |
| Price to Sales | 9.31 |
| Price to Book Ratio | 5.59 |
| Enterprise Value to Revenue | 7.73 |
| Enterprise Value to EBIT | 25.25 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.13 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.6979▲ 68.53% |
|---|---|
| Total Calls | 976,000▲ 9.39% |
| Total Puts | 1,657,175▲ 83.42% |
Holdings and activity of institutional investors.
| Ownership % | 69.70%▲ 1.31% |
|---|---|
| Total Invested | $2.67B▼ 9.64% |
| Investors Holding | 379▼ 68.00% |
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...